Persistence of West Nile virus-specific antibodies in viremic blood donors

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1228-1230

  Prince, Harry E ^a,c   Tobler, Leslie H ^b   Yeh, Cindy ^a   Gefter, Nelly ^b   Custer, Brian ^b   Busch, Michael P ^b  

^a Focus Diagnostics Inc   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RNA;

ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; WEST NILE FEVER; WEST NILE VIRUS;

EID: 34948909752     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00233-07     Document Type: Article

References (9)

1. Busch, M. P., S. Caglioti, E. F. Robertson, J. D. McAuley, L. H. Tobler, H. Kamel, J. M. Linnen, V. Shyamala, P. Tomasulo, and S. H. Kleinman. 2005. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N. Engl. J. Med. 353:460-467.
2. Centers for Disease Control and Prevention. Accessed 17 May 2004. 2004 West Nile virus activity in the United States. Centers for Disease Control and Prevention, Atlanta, GA. http:/www.cdc.gov/ncdod/cvbia/westnile/ surv&control06Maps.htm.
3. Hogrefe, W. R., R. Moore, M. Lape-Nixon, M. Wagner, and H. E. Prince. 2004. The performance of West Nile virus recombinant (preM/E)-based immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assay for detection of West Nile virus- and other flavivirus-specific antibodies. J. Clin. Microbiol. 42:4641-4648.
4. Lanciotti, R. S. Accessed 11 May 2004. Current laboratory protocols for West Nile virus. Centers for Disease Control and Prevention, Atlanta, GA. www.cdc.gov/ncidod/dvbid/westnile/conf/February_2004.htm.
5. Petersen, L. R., and A. A. Marfin. 2002. West Nile virus: a primer for the clinician. Ann. Intern. Med. 137:173-179.
6. Prince, H. E., and M. Lape-Nixon. 2005. Evaluation of a West Nile virus immunoglobulin A (WNV IgA) capture enzyme-linked immunosorbent assay (ELISA). Clin. Diagn. Lab. Immunol. 12:231-233.
7. Prince, H. E., L. H. Tobler, M. Lapé-Nixon, G. A. Foster, S. L. Stramer, and M. P. Busch. 2005. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J. Clin. Microbiol. 43:4316-4320.
8. Roehrig, J. T., D. Nash, B. Maldin, A. Labowitz, D. A. Martin, R. S. Lanciotti, and G. L. Campbell. 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 9:376-379.
9. Stramer, S. L., C. T. Fang, G. A. Foster, A. G. Wagner, J. P. Brodsky, and R. Y. Dodd. 2005. West Nile virus among blood donors in the United States, 2003 and 2004. N. Engl. J. Med. 353:451-459.